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A B S T R A C T   
Background: Experience-Based Co-Design (EBCD) is a participatory design method which was originally devel-
oped and is still primarily used as a healthcare quality improvement tool. Traditionally, EBCD has been sited 
within single services or settings and has yielded improvements grounded in the experiences of those delivering 
and receiving care. 
Method: In this article we present how EBCD can be adapted to develop complex interventions, underpinned by 
theory, to be tested more widely within the healthcare system as part of a multi-phase, multi-site research study. 
We begin with an outline of co-design and the stages of EBCD. We then provide an overview of how EBCD can be 
assimilated into an intervention development and evaluation study, giving examples of the adaptations and 
research tools and methods that can be deployed. We also suggest how to appraise the resulting intervention so it 
is realistic and tractable in multiple sites. We describe how EBCD can be combined with different behaviour 
change theories and methods for intervention development and finally, we make suggestions about the skills 
needed for successful intervention development using EBCD. 
Conclusion: EBCD has been recognised as being a collaborative approach to improving healthcare services that 
puts patients and healthcare staff at the heart of initiatives and potential changes. We have demonstrated how 
EBCD can be integrated into a research project and how existing research approaches can be assimilated into 
EBCD stages. We have also suggested where behaviour change theories can be used to better understand 
intervention change mechanisms.   
Introduction 
Experience-Based Co-Design (EBCD) is a participatory design 
method that was originally developed, and is still primarily used, as a 
healthcare quality improvement tool.1 It is a multi-stage process 
involving patients, carers and staff in identifying how healthcare ser-
vices can deliver enhanced experiences to improve care. As an 
improvement tool it has combined four main underpinning approaches:  
i. participatory action research,  
ii. user centred design,  
iii. learning theory, and  
iv. narrative-based approaches to change.2 
The method has been mainly used in single sites to improve patient 
experiences of local services. However, EBCD can be integrated into 
projects to realise complex interventions, which can then be tested more 
widely within the healthcare system. Recently, the unrealised potential 
of EBCD to develop complex healthcare interventions as part of a wider, 
multi-phase research study has been highlighted.3 To address this, we 
outline how EBCD can be integrated into an intervention design and 
evaluation project embedded within a multi-site research project. We 
use the example of developing complex interventions, underpinned by 
behaviour change theory, to increase the safety of medicines manage-
ment. In doing so, we discuss the use potential use of EBCD in the context 
of medicines optimisation research and offer practical tips on how re-
searchers can adapt this method to develop and evaluate interventions. 
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Medicines are the most commonly used healthcare intervention 
worldwide and are fundamental in the management and prevention of 
health conditions. In the United Kingdom (UK), the National Health 
Service (NHS) spends approximately £16 billion a year on medicines 
across primary and secondary care. Yet whilst medicines are a 
frequently used intervention, they are managed through systems that are 
highly error prone, producing the potential for patient harm in the 
prescribing, dispensing and administering parts of the system.4 Globally, 
each year an estimated US$42 billion is associated with medication er-
rors.5 Consequently, reducing avoidable harm associated with medi-
cines errors by half by 2022 is the subject of a worldwide campaign by 
the World Health Organization (WHO).5 
Numerous interventions to reduce harm from medicines have tar-
geted different stages in the management process,6,7 and many of which 
are aimed at patients’ use of medicines, including the acquisition of 
skills to self-manage medicines.7 However, it is difficult to discern if or 
how patients have been involved in intervention development. We also 
know that patients play a proactive and safety-critical role in managing 
their medicines, undertaking tasks independently of healthcare pro-
fessionals and without their guidance or support.8–10 Indeed, there is a 
demonstrated link between improved patient experiences and both pa-
tient safety and clinical effectiveness in healthcare.10 As such, building 
on the skills that many patients clearly have is crucial, for example 
through understanding and building on their medicines management 
routines and experiences through involving them in developing in-
terventions to enhance safety. Table 1 outlines areas of medicines 
management where co-design approaches could be used to develop in-
terventions to improve care. 
To realise such complex interventions, there is an established UK 
guideline – developed by the Medicines Research Council (MRC) – rec-
ommending the processes involved in their development and evalua-
tion.11 There is limited detail in the guidance about intervention 
development. However, O’Cathain et al. have developed (from sys-
tematic review) a taxonomy of approaches to doing this, the first being 
the ‘partnership approach’. Here, people who will use the intervention 
participate equally with the research team throughout intervention 
development.12 When well-designed and managed, EBCD offers exactly 
such an approach. Here we will outline how EBCD can be combined with 
the guidelines for intervention development and be underpinned by 
theory whilst still being grounded in and built from the experiences of 
the people it targets. First, we offer a brief introduction to co-design. 
What is co-design? 
Traditionally, industry has designed products for people or with 
people’s needs in mind.13 Methods where designers and end-users work 
together, as equal partners, to design new products, have been 
increasingly popular. Co-design, as one method of developing products 
and services, has been used for decades in the fields of business mar-
keting, design, IT and architecture.14 It goes beyond basic stakeholder 
consultation, or observation, to encourage joint working aiming to 
create solutions. It is participatory in nature, where the basic principle is 
to bring stakeholders (researchers, designers, end users etc.) together to 
work collectively during a design process.15 The value of co-design is the 
sharing of varied perspectives in order to understand both ‘demand’ and 
‘supply’ – in order to create successful outputs. Most importantly, by 
involving the end-user, more innovative ideas that better match users’ 
needs are generated. In doing this, evidence demonstrates an overall 
improved customer satisfaction.15 
The concept of co-design has been adopted within healthcare quality 
improvement practices. Here, staff and patients associated with a 
particular service work together to design different ways of working. Co- 
design has resulted in tangible improvements in, for example, breast 
services,16 bedside handovers, and communication at hospital 
discharge.17 
Co-design for healthcare involves engagement with, and empower-
ment of, those individuals (staff and patients) with lived experience. It 
aims to advance quality of life and health outcomes for all involved.18 
Whilst co-design has notable benefits, it also has limitations. For 
example, it is important to plan stakeholder engagement carefully to 
ensure involvement is meaningful and beyond the tokenistic. 
Whilst co-design is increasing in popularity, its use has mainly been 
within quality or service improvement projects. There is, however, 
growing evidence of researchers using co-design within larger inter-
vention development research projects. For example, Hahn-Goldberg 
et al. used participatory action research to inform the co-design of a 
patient-oriented discharge summary,19 and Tsianakas et al. used EBCD 
to develop an intervention in a chemotherapy outpatients service to take 
forward to acceptability and feasibility research.20 These approaches 
require different considerations than when designing an EBCD study for 
local service improvement. 
What is experience-based co-design? 
One method of co-design increasingly used in healthcare is EBCD, 
originally known as Experience-Based Design (EBD). Using EBCD, the 
experiences of those who use and deliver healthcare services are 
explored. Together, groups identify ways in which services can be 
adapted to improve those experiences. Traditionally, EBCD has been 
used as a service improvement technique focussing on the experiences 
and emotions of healthcare service users. It has done this through elic-
iting the points in the patient pathway where people’s experiences of 
services are defined (‘moments of truth’ or ‘touchpoints’). Those who 
developed the method emphasise its focus on designing experiences 
rather than processes.21 EBCD was first developed and piloted in 2005–6 
in a UK head and neck cancer service.22 This work identified care 
touchpoints related to the physical environment in which care was 
experienced, for example a queuing system for clinical check-in 
confused and embarrassed patients. Other examples were weighing 
patients in a public place, and patients had problems reaching the 
bedside bell to attract attention when experiencing post-operative 
problems.22 Since this first study, EBCD has been widely used: a 2013 
survey found that 59 EBCD projects had been conducted or were un-
derway in the UK, Australia, New Zealand, Canada, Sweden and the 
Table 1 
Potential areas that would benefit from co-designed medicines management 
interventions.  
Area of focus Co-design potential to make use of patients’ 
medicines management expertise 
Medicines self-management Patient skills, strategies and tools to effectively and 
safely manage their own medicines, including error 
mitigation and error management, supply 
management, support that can be leveraged, 
support for communication with healthcare 
professionals. 
Medicines optimisation at 
care transitions 
Interventions to optimise how patients can prepare 
for moving from hospital to home, managing 
ongoing supply ordering and collection, adapting 
routines to take into account changes made in 
hospital, ongoing communication with healthcare 
professionals about management of medicines at 
care transitions, such as patient follow-up support 
with medicines by community pharmacy after 
discharge from hospital. 
Managing medicines with 
regular dose changes 
Interventions to support patients after doses have 
changed to understand how strategies and tools 
could help them check their prescriptions reflect 
those changes and manage their supplies. 
Shared decision-making for 
prescribing 
Interventions to support patients in their 
consultations with staff about prescribing decisions, 
for example in the choice of medicines or whether 
to discontinue a medicine, and ongoing 
management and support after a medicine has been 
changed.  
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Netherlands for a range of services and conditions. These included 
palliative care, neonatal care, orthopaedics, cancer, mental health, and 
diabetes.23 At this time there were no EBCD studies focussing solely on 
the medicines management system. A 2020 systematic review of pub-
lished studies included one study focussing on multi-morbid patients for 
whom managing polypharmacy was a priority.24 
Traditionally sited within single services or settings, EBCD has suc-
cessfully yielded improvements through enhanced patient and staff 
involvement – grounded in the experiences of those delivering and 
receiving care in those places. Lately, however, the method has been 
adapted as part of a UK National Institute of Health Research 
Programme Grant for use in intervention development which is:  
• embedded within a larger programme of research  
• across multiple sites and  
• across transitions of care which form structural gaps in the safety and 
continuity of care.25 
In this research project, the team (including three of the authors of 
this work) adapted EBCD to provide a systematic way to prioritise the 
real-world problems experienced universally by patients in the man-
agement of their medicines, which were common across sites. It 
Fig. 1. Stages, purpose and outputs of multi-site complex intervention development using Experience Based Co-Design (EBCD).  
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included a range of stakeholders in intervention design – focussing on 
the parts of the system where change could help improve both patient 
experience and safety. The resulting co-designed interventions were 
deconstructed into individual components and each component was 
mapped onto the taxonomy of behaviour change techniques (BCTs)26 to 
understand how those components could effect change, whether it be 
through helping patients understand changes to their medicines, how 
they could identify problems such as incorrect prescriptions or if they 
started to become unwell, or to provide practical support in managing 
medicines. After stakeholder consensus determined which components 
were likely to be deliverable, acceptable and effective the intervention 
(the Medicines at Transitions Intervention) then underwent feasibility 
testing,27 and is now the subject of a national clinical cluster randomised 
control trial and process evaluation in 42 healthcare trusts.28 The 
outcome measures of interest were all cause mortality and readmission 
to hospital, along with secondary outcomes including knowledge of 
medicines and satisfaction with medicines-related care. 
What are the stages of EBCD? 
There are several, well-documented stages to delivering EBCD which 
usually take up to one year to complete.29 However, an accelerated 
version of EBCD exists to facilitate completing the process within a 
shorter timeframe.30 Importantly, patients should be full partners in this 
process and be represented on the project steering group, and not just 
participants in the co-design stages. A full EBCD toolkit, is available 
online, which takes users through how EBCD works as a quality 
improvement tool.31 
In short, the main full EBCD stages comprise:  
• Project set-up, including establishing a steering group and training of 
staff and patient representatives.  
• Observations of service delivery and interviews with patients and 
staff. Observations can be conducted in different settings, for 
example in hospital, ward observations can shed light on the way 
care is delivered to patients. This could include the degree of patient 
involvement in conversations about medicines, or how medicines 
supplies are obtained by patients. In the community, observations 
could take place in clinics, in community pharmacies, or in GP 
practices.  
• Staff and patient interviews to understand experiences of giving and 
receiving care and to identify emotional touchpoints.  
• Patient interviews are filmed and a short (20–30 min) trigger film is 
produced that communicates their experiences and the impacts of 
the emotional touchpoints on them. The trigger film is particularly 
effective at communicating aspects of the patient experience that are 
invisible to staff. For example, hospital staff may not be aware of how 
confused patients can be about their medicines once they are at home 
after being discharged, or the errors that patients experience, such as 
mistakes in repeat prescriptions following a spell in hospital.  
• Group meetings with staff to review the evidence from observations 
and interviews and suggest priorities for change.  
• Group meetings with patients to view the trigger film, create an 
emotional map for their care experiences and suggest priorities for 
change.  
• A joint event during which staff and patients watch and discuss the 
trigger film and then agree priorities for service improvement.  
• Facilitated, co-design groups including patients and staff work on 
creating tools or redesign services to address the agreed priorities  
• A celebration event to reflect on the EBCD process and recognise the 
achievements of staff and patients who took part. 
Adapting EBCD for complex intervention development and testing as 
part of a multiphase project 
The MRC guideline intervention development, evaluation and 
implementation process in healthcare comprises five main stages:  
1. development,  
2. piloting and feasibility,  
3. evaluation,  
4. reporting and  
5. implementation.32,33 
EBCD sits well within the development phase of the process, 
although it should be combined with essential steps of: 
• identifying the evidence base in the relevant area (through con-
ducting or identifying a systematic review), and  
• conducting empirical research to inform the theory of change for the 
resulting intervention. 
EBCD is easily adaptable here as its early stages involve interviews 
with patients and healthcare staff. For example, in the early stages of our 
project to develop an intervention to support safe medicines manage-
ment at transitions of care for older people with frailty, Tomlinson et al. 
conducted a systematic review to establish the characteristics of effec-
tive interventions.34 We then used the interview stage of EBCD to 
conduct qualitative research in two healthcare areas with older people 
after discharge from hospital, analysed using the Framework method.35 
Interviews generated the EBCD trigger film as well as a robust evidence 
base to support the process of change, which could then be mapped on to 
existing change theories (see Combining EBCD with different theories and 
methods for complex intervention development). 
When designing research incorporating EBCD, methodological con-
siderations need to be considered which hallmark the project as 
research. As a research project, the research settings need to be chosen 
so that they represent a wider population, which is different to focussing 
on a local problem to initiate a quality improvement programme. In this 
way the transferability of the qualitative results can be optimised. To 
develop a medicines management complex intervention that has the 
potential to be implementable for a wider population, selecting multiple 
sites so that different site characteristics that may influence service de-
livery and patient experiences can be explored. For example, in our 
recent study four different acute secondary care sites were selected to 
conduct the qualitative phase to capture variations in practice, local 
pathways and in the patient population.9 Further to this, patient and 
staff sampling frames will need to represent the wider population of 
interest, rather than just patients in one single setting. 
The stages, purpose and outputs of complex intervention develop-
ment using EBCD are outlined in Fig. 1. As adapted for use in research – 
rather than directly as a service quality improvement tool – the in-
terviews that feed into the production of the trigger film are analysed 
qualitatively to produce a research evidence base. As the project is 
research, rather than local quality improvement, the necessary ethical 
opinions and approval must be sought. 
Analysis of the interview data can be supported by appropriate 
methods, for example, Framework35 or thematic analysis.36 A review of 
EBCD projects has found that the majority systematically analysed 
interview data using a range of methods.3 The interview data can also be 
combined and synthesised with data from observational research and 
routine data sources, such a local and national policies. This can be done 
across multiple settings to create a more robust research project and an 
intervention that can implemented in diverse environments. All the 
available data might be considered as forming a bounded case-study.37 
What range of data types are used and how it is combined will reflect the 
purpose of the research project and the ontological or epistemological 
assumptions of the various stakeholders. 
The separate patient, staff and joint events can bring together in-
dividuals associated with multiple healthcare organisations within 
larger care systems.38 This is beneficial when considering healthcare at 
transitions and the patient pathway is complex.39 However, the prior-
ities agreed and potential solutions designed may reflect a particular 
context and local processes. In other words, the solutions designed may 
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require further adaptation for implementation across a system of care or 
in different geographies. 
Users and carers who experience the whole care pathway may easily 
appreciate the usefulness of multi-site EBCD that brings together 
different parts of a system. However, some may be more interested in 
local service improvement. Moreover, healthcare staff may be less 
invested in discussions that do not directly influence their immediate 
working environment or the parts of the pathway that they usually see. 
When adapting for a multi-site research project with plans for a future 
large-scale evaluation, the scope to make local improvements as a result 
of EBCD should be agreed with each site. Changes to local practice may 
be deemed necessary after staff and patients view the trigger film and 
take part in co-design activities, however and changes made might 
preclude those sites from participating in future evaluations because 
their model of usual care may change to be too close to the intervention 
being trialled. 
The success of multi-site EBCD depends on the identification of 
willing volunteers with the time and experience to work for the common 
good. Clearly, some incentives and adaptations are required to cover 
stakeholder expenses and provide universal access to meeting locations. 
However, this philosophy fits with the concept of integrated care sys-
tems,38 and the smoothing out of transitions between levels of care. 
Table 2 
Differences in flexibility of interventions developed through EBCD for local 
improvement and for multi-site evaluation.  
EBCD for local quality improvement EBCD for complex interventions for 
multi-site evaluation 
Changes can be made quickly, and 
differences observed. 
An intervention must be defined and 
once the trial study protocol is set and 
patients are recruited, interventions 
cannot easily be changed. 
Implementation can be managed locally The intervention may need to be flexible 
to adapt to local contexts, such as the 
type of staff involved in delivery. 
A multi-site feasibility study can help 
understand the flexibility needed to 
implement the intervention more 
widely. 
Local testing/feedback can offer an 
assessment of whether the intervention 
improves experiences.43 
The site may continue to deliver the 
improved service. 
No assumptions are made about whether 
the intervention is effective in advance 
of the trial results. 
Clear outcome measures need to be 
established. 
No sites will continue to deliver the 
intervention once trial data is collected.  
Table 3 
Stages to integrate EBCD into an intervention development and evaluation research project.  
Stage Adaptations and research methods needed 
Research design phase  • Identify or conduct literature review  
• Specify your research questions and objectives.  
• Empirical research design including selecting the underpinning theories, selection of research sites to represent populations of 
interest and to capture different models of care deliver, sample design, data collection plan and analysis methods.  
• Ethical and governance approvals 
Non-participant observations  • Observations are performed by researcher rather than service providers.  
• Information sheets and consent forms for observations  
• Observation schedule (based on the theoretical approach taken)  
• Field note booklets 
Staff qualitative interviews  • Interview guide (informed by the theoretical approach taken). Information sheets and consent forms  
• Audio recording devices 
Patient/carer qualitative interviews  • Interview guide (informed by the theoretical approach taken)  
• Information sheets and consent forms  
• Audio and video recording devices 
Synthesis and qualitative analysis  • Data collected from observations and interviews are analysed using qualitative methods, such as Framework analysis,38 or narrative 
analysis which can elicit meaning from patient and staff stories.48  
• Fylan et al.6 and Tomlinson et al.7 are examples of medicines safety and continuity research programmes using qualitative research 
as the first stage of EBCD. 
Trigger film editing  • The trigger film is edited from the video recordings of patient interviews focussing on emotional touch points.  
• A patient representative should be involved in helping identify the relevant parts of the footage.  
• This stage is managed separately from the synthesis and qualitative analysis of observations and patient and staff interviews. The 
film should tell the story of how patients experience the care they receive rather than the story of the data analysis. 
Patient feedback event  • This event supports patients in an emotional mapping of their care journey and setting priorities for change.  
• Taking careful notes of the emotional maps and priorities is essential.  
• You may run more than one of these events depending on the number of sites 
Staff feedback event  • This event offers feedback on research findings and support priority setting. You should document the priorities for change 
generated by staff. 
Joint event  • Document the agreed priorities and how they have been allocated. 
Co-design groups  • Participants are facilitated to develop prototypes or plans for change, which can be mapped onto the priorities generated. Teams can 
use a range of creative methods, such as character vignettes to aid their thinking, and craft materials or props can be used to help 
realise prototype interventions. We have witnessed how patients really want to be listened to and enjoy being practical, hands on, 
and seeing the results of their work.  
• Prototypes from different groups can be broken down into components and compared against the evidence-base generated from 
qualitative research and systematic review. 
Building the intervention  • Components that will form the intervention can be agreed through stakeholder consensus, for example through an expert panel of 
patients and healthcare staff. Each component can be rated against specific criteria agreed by the wider research team and patient 
advisers. One such set of criteria to assess the components are the APEASE criteria: affordability; practicability; effectiveness and 
cost-effectiveness; acceptability; side-effects and safety; equity.40 
Intervention mapping  • Logic models44 or a theory of change45 can be developed using frameworks such as the Behaviour Change Technique Taxonomy.26 
User-testing, feasibility study and 
intervention refinement  
• User-testing of patient-facing tools such a medicines information and a feasibility-testing phase will explore how your intervention 
will operate in a clinical environment.  
• Sites should be chosen to reflect diversity in population and models of care delivery so that necessary adaptations can be identified 
for a multi-site trial.  
• Observations and qualitative research with patient and healthcare staff will uncover important barriers and facilitators to successful 
intervention implementation.  
• A TIDieR checklist46 can be used to describe the refined intervention and a user guide developed for implementation.  
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As is shown in Fig. 1, EBCD is an sequential process. Each step has 
defined outputs which are reviewed and built on in the subsequent steps. 
EBCD is to an extent ‘self-healing’ and incorporates reflection.  
• This means participants have ample opportunities to suggest, create 
and refine ideas; whether these relate to problems (priorities) or 
solutions.  
• It also carefully builds stakeholder consensus whilst privileging the 
views and experience of service users.  
• It has the capacity to ‘bring along’ divergent viewpoints and 
individuals.  
• The entire process is conducted transparently, and participants can 
readily see if their suggestions influence the deliverables at each step. 
In our experience, the trigger film is the key that unlocks common 
purpose and joint effort. This model of intervention development en-
sures that the overall objective of change (improved care for patients) is 
not lost and that, if needed, focus can easily be restored. 
When using EBCD as part of the process of developing complex in-
terventions, some care is necessary to ensure that proposed solutions are 
realistic and tractable in multiple locations where they may need to 
adapt to local requirements. For example, the APEASE criteria (afford-
ability, practicability, effectiveness and cost-effectiveness, acceptability, 
side-effects and safety, equity)40 can be applied using consensus 
methods41 and/or expert judgement. EBCD allows creative solutions to 
flow from service participants, however, research considerations require 
that these solutions are screened and validated. When EBCD is used for 
quality improvement in a single location any implementation issues can 
be easily resolved in the next rapid iteration, for example using Plan, Do, 
Study Act cycles.42 However, when a complex intervention is being 
developed for trial, the proposed interventions arising from EBCD will 
be fixed within the evaluation study protocol and fidelity to the inter-
vention will be assessed during the trial phase. The intervention devel-
oped may, however, need to be flexible enough to be delivered in 
different sites and to allow for contextual factors and here an imple-
mentation framework would be useful. We have found with our in-
terventions the feasibility study stage consolidates knowledge of how 
the intervention can accommodate local variation. Sites that are 
involved in development of EBCD locally may implement the interven-
tion for local improvement, but we cannot assume that the intervention 
will bring about improvement in new sites trialling it as part of a 
multi-site evaluation. Consequently, once evaluation data collection is 
complete, those trial sites should stop delivering the intervention until 
the results are available. These differences are highlighted in Table 2. 
A useful step is the production of logic models44,45 for all elements of 
the complex intervention and completion of a TIDieR checklist.46 The 
logic model(s) will relate the practical aspects of the intervention to 
underpinning theories or mechanisms and outcomes that have previ-
ously been achieved. Intervention development will usually conclude 
with the production of an intervention manual to instruct those 
responsible for implementation.47 
An overview of the materials necessary for implementing EBCD as a 
research project is shown in Table 3. 
Combining EBCD with behaviour change theories and methods for 
complex intervention development 
Different theories have been used in the literature to guide inter-
vention design and implementation,49–51 aiming to improve effective-
ness and uptake. In this article, we acknowledge there are many 
theoretical lenses that could underpin intervention design, but we focus 
our attention on the example of behaviour change theory. This is 
because an understanding of the likely behavioural mechanisms that 
will bring about change are instrumental when designing our inter-
vention to improve medication safety. There is also a recognition that 
behaviours and systems, such as medicines management, are complex. 
Researchers will often use underpinning theories to help them design 
their studies, interpret the data, and to help them understand 
phenomena.48 Intervention development should be underpinned by a 
sound theoretical basis as this is more likely to result in effective design 
and implementation.33 Many studies have used theory in this way to 
inform the design of their interventions by considering all influential 
factors. Some studies may choose to underpin their intervention design 
by implementation theory (for example, the Consolidated Framework 
for Implementation Research),52 which looks at system wide factors that 
can help with the uptake of new interventions. Others, such as ours, may 
choose to use behaviour change theory to identify the behavioural 
barriers and enablers which the intervention can be designed to target. 
Kok et al. state that effective interventions will:  
• target key determinants that predict the behaviour that needs to 
change,  
• use techniques that are able to modify key determinants, and  
• fit the target population, culture and context.53 
Clearly, co-design with patients and healthcare staff is beneficial and 
useful in achieving these ideals. EBCD, used as a research method for 
intervention design, rather than service improvement, is different as it 
will often first require the identification or development of appropriate 
theory. This can somewhat complicate the EBCD process as the 
researcher needs to find methods of synthesising their chosen theory 
with EBCD output. The theory needs to underpin the methods of EBCD, 
as well as inform the design of the intervention. Suggestions of how we 
have thoughtfully combined theory and EBCD and used them synergis-
tically are displayed in Table 4. 
There are many theories that can be used to help make sense of 
intervention design and a discussion of them all is outside the scope of 
this article. We shall instead focus on our application of behaviour 
change theory, with EBCD, through the use of:  
• the Theoretical Domains Framework (TDF),54  
• the Behaviour Change Technique Taxonomy (BCTT),26 and  
• the COM-B system.40 
We have chosen to underpin our intervention development of a care 
transition intervention for older people living with frailty with behav-
iour change theory, namely because we want someone (a patient, family 
carer or healthcare professional) to do something differently to promote 
medicines safety. Here, we have applied behaviour change theory to 
help identify the barriers and facilitators to performing the chosen 
behaviour (for example, medicines adherence, safe prescribing habits 
Table 4 
Synergistic use of EBCD and theories of behaviour change.  
Step of behaviour change theory- 
informed intervention design 
How EBCD can be utilised 
Identify the key determinants of 
behaviour  
• EBCD participants review the trigger film 
and generate emotional touchpoints, which 
can also come from their own experiences.  
• Priorities for improvement are identified 
from the touchpoints that the researcher 
needs to then consider in terms of behaviour. 
Identify the techniques that target 
these determinants  
• EBCD participants can select techniques 
(from validated lists, literature search, etc.) 
they feel would be most efficacious in the 
given context, based on their personal 
experiences. 
Model to fit the target population, 
culture and context  
• Design of the intervention content closely 
involves those that will deliver (healthcare 
staff) and receive the service (staff or 
patients).  
• Event activities designed to elicit 
perspectives on acceptability, practicality 
and cost-effectiveness.  
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etc) and prioritise suitable evidence-based intervention components that 
will promote your target behaviour by overcoming the barriers and 
enhancing the facilitators. The TDF, BCTT and COM-B are all potential 
tools that can be used to underpin EBCD methods. How we have applied 
these theories to our EBCD work is demonstrated in Table 5. By bringing 
theory into the EBCD process, participants are provided with an op-
portunity to interrogate academic processes of intervention design, and 
cognitively challenge what the theory tells us is the right course of 
action. 
Skills needed for successful complex intervention development using EBCD 
First, a highly collaborative, multi-disciplinary team that includes 
patients and carers is necessary. Research skills are crucial to the 
interview and observation stage, for example, qualitative interviewing 
skills, non-participant observation skills and the ability to manage, 
analyse and synthesise data. Second, the ability to tell a story of the 
experience of care is crucial, this is done through translating patient 
stories to the trigger film, exploring the emotional map of care with 
patients and through presentations at the EBCD joint event. 
Increasingly, we are convinced that bringing on board an expert 
design team to help bring co-design groups’ ideas to life is an essential 
step. We have found that both patients and staff can be bounded by the 
horizons of what they feel the health service can achieve and by their 
own experiences of receiving and delivering care, for example we have 
found that co-design groups have favoured developing information 
booklets to support use of medicines because they are used to giving or 
being given information. To help break though this, designers can bring 
ideas to life in unexpected ways, for example through helping co-design 
groups visualise solutions for medicines management differently by 
using character vignettes. We have witnessed how patients and staff 
really enjoy being hands-on in creating physical prototypes, and seeing 
the results of their work. 
Engaging patients from the planning stage helps guide the study 
towards issues that are important to patients. Patients can also support 
developing study materials, offer advice about recruitment, co-edit the 
trigger film, and advise about interpretation of results. Patients have 
supported us throughout the lifecycle of several EBCD projects, one of 
which has developed an intervention for clinical trial. Patients in this 
group, all heart failure patients, or carers, have also been co-analysts of 
data collected during the trial’s qualitative process evaluation.55 
Finally, it is important to ensure the research team has access to 
collaborators with the appropriate skills to map the intervention onto 
the chosen theory or framework, understand the mechanisms with 
which it will effect change and how that change can be evaluated. 
Having a clearly documented and measurable outcome derived from the 
early empirical research, literature review and stakeholder conversa-
tions will aid this process. 
Summary 
EBCD has been recognised as being a collaborative approach to 
improving healthcare services that puts patients and healthcare staff at 
the heart of initiatives and potential changes and, as such, it is preferable 
to top-down service re-organization approaches. We have demonstrated 
how EBCD can be integrated into a research project that aims to develop 
and test an intervention supported by behaviour change theory to 
enhance the safety and continuity of medicines and suggested how 
existing research approaches can be assimilated into EBCD stages. We 
have also suggested where behaviour change theories can be used to 
inform EBCD and to better understand intervention change mechanisms. 
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Table 5 
Combining EBCD with behaviour change theories to underpin intervention design.  




A validated, broad framework of 14 (originally 12) 
theoretical constructs (for example, skills, knowledge, 
emotion etc.) relevant to behaviour change 
determinants, identified from 33 theories.  
• Researchers map the determinants of behaviour arising 
from the qualitative interviews to the constructs of the 
TDF.  
• This is validated by EBCD participants, giving an 
understanding of the barriers and enablers to 
behaviour change which can help prioritise the 
intervention mode of action and content. 
EBCD participants may need some 
training to help support this level of 
analysis. 
Using the TDF allows participants to 
consider a wide range of factors that 




A list of 93 behaviour change techniques, categorised 
into 16 clusters, linked to each theoretical construct of 
the TDF.  
• Key determinants of behaviour can be transparently 
and systematically mapped (via the TDF) to 
appropriate behaviour change techniques that are 
likely to result in behaviour change.  
• EBCD participants can then develop the intervention 
using these as a starting point. 
The taxonomy is developed from 
public health interventions so some 
will not be relevant in your context. 
Some BCTs might be challenging to 
operationalise in real-life practice. 
COM-B model40 Framework that considers the capability, opportunity 
and motivation that drives behaviour. This is 
positioned within nine intervention functions and 
seven policy categories that could enable the 
intervention to occur.  
• Participants can offer unique insights into capability, 
opportunity and motivation factors.  
• They are prompted to consider which functions and 
policy categories would be useful to promote behaviour 
change based on their experiences of care. 
A broad model that considers the 
concepts and contexts necessary for 
intervention design. 
Can be considered reductionist 
however, and therefore nuanced 
meaning can be lost.  
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expert advice and the ISCOMAT programme team. 
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